Innate Pharma Plans To Launch IPO On Euronext Oct. 31, 2011 By James Etheridge No Comments No AbstractRead More
Transgene Signs Pact To Work With National Cancer Institute Oct. 31, 2011 By James Etheridge No Comments No AbstractRead More
Eurofins Scientific Aims To Become World-Class CRO Oct. 31, 2011 By James Etheridge No Comments No AbstractRead More
Biosystems International Aiming For Drug, Diagnostic Biomarkers Oct. 31, 2011 By James Etheridge No Comments No AbstractRead More
SpePharm Seeking €35M from BioAlliance Pharma April 22, 2009 By James Etheridge No Comments No Abstract BioWorld International CorrespondentPARIS - SpePharm Holding BV plans to file a claim against BioAlliance Pharma SA for financial damages and losses of at least €35 million (US$45.3 million).Read More
